PLRX

Pliant Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in South San Francisco, California, dedicated to the development of innovative therapies for fibrosis and related diseases. The company is advancing a promising pipeline that includes treatments for idiopathic pulmonary fibrosis, aiming to fulfill significant unmet medical needs in this challenging area of healthcare. Leveraging deep expertise in fibroblast biology and small molecule drug development, Pliant is positioned to become a leader in the biopharmaceutical industry, committed to delivering transformative therapies that enhance patient outcomes and drive advancements in medical care.